|
|
Efficacy of Modified Dachaihu Decoction combined with Octreotide Acetate Injection in the treatment of severe acute pancreatitis and its ibfluence on the level of serum tumor necrosis factor |
LIN Ping-qing1MIN Jun1DIAO Liang-biao2 |
1.Department of Emergency,Fuzhou Second Hospital Affiliated to Xiamen University,Fujian Province,Fuzhou 350007,China; 2.Department of Nephrology,Fuzhou Second Hospital Affiliated to Xiamen University,Fujian Province,Fuzhou 350007,China |
|
|
Abstract Objective To explore the effect of modified Dachaihu Decoction combined with Octreotide Acetate Injection in the treatment of severe acute pancreatitis and its influence on the level of serum tumor necrosis factor.Methods From January 2018 to December 2020,80 patients with severe acute pancreatitis who were admitted to Fuzhou Second Hospital Affiliated to Xiamen University were selected as the study subjects.According to the random number table method,they were divided into the control group(40 cases)and the observation group(40 cases).The control group was treated with Octreotide Acetate Injection,and the observation group was treated with Modified Dachaihu Decoction on the basis of the treatment of the control group.The therapeutic effects,the incidence rate of adverse reactions,intestinal mucosal barrier function,and the level of serum tumor necrosis factor were compared between the two groups.Results The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).The total incidence rate of adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).The levels of plasma endotoxin,plasma diamine oxidase and urinary lactulose/mannitol in the two groups after treatment were lower than those before treatment,and the differences were statistically significant(P<0.05).The levels of plasma endotoxin,plasma diamine oxidase and urinary lactulose/mannitol in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of interleukin-6 (IL-6),tumor necrosis factor-α(TNF-α)and interleukin-8 (IL-8)after treatment in the two groups were lower than those before treatment,and the differences were statistically significant(P<0.05).The levels of IL-6,TNF-α and IL-8 in the observation group after treatment were lower than those in the control group,and the differences were statistically significant(P<0.05).Con-clusion Modified Dachaihu Decoction combined with Octreotide Acetate Injection in the treatment of severe acute pancreatitis can improve the effective rate of treatment,and significantly improve patients′intestinal mucosal barrier function and level of serum tumor necrosis factor,which is worthy of clinical popularization and application.
|
|
|
|
|
Cite this article: |
LIN Ping-qing,MIN Jun,DIAO Liang-biao. Efficacy of Modified Dachaihu Decoction combined with Octreotide Acetate Injection in the treatment of severe acute pancreatitis and its ibfluence on the level of serum tumor necrosis factor[J]. 中国当代医药, 2021, 28(31): 177-180.
|
|
|
|
URL: |
http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I31/177 |
[1] |
解淑萍,张新,曹志群,等.大柴胡汤加减联合醋酸奥曲肽注射液治疗重症急性胰腺炎临床研究[J].山东中医药大学学报,2017,41(6):540-542.
|
[2] |
陈甡.大柴胡汤加减联合西药治疗重症急性胰腺炎的效果及对炎症因子水平的影响[J].大医生,2020,5(20):105-107.
|
[3] |
平立英,周哲,杨素云,等.奥曲肽联合连续性肾脏替代疗法对急性重症胰腺炎患者血清M30及M65表达的影响[J].中国医院用药评价与分析,2020,20(10):1204-1207.
|
[4] |
周克聚,刘静,高小虎,等.大柴胡汤加减联合生长抑素治疗重症急性胰腺炎临床观察[J].河南中医,2018,38(8):1152-1154.
|
[5] |
王萍,叶蜀辉.大柴胡汤联合地塞米松对重症急性胰腺炎胰腺血流及胃肠功能相关指标的影响[J].新中医,2019,51(8):60-63.
|
[6] |
郑五州,王永胜,杨志磊.柴胡承气汤联合醋酸奥曲肽注射液治疗重症急性胰腺炎效果分析[J].青岛医药卫生,2020,52(5):347-349.
|
[7] |
古丽齐曼·艾尔肯,阿达来提·艾力.注射用乌司他丁联合醋酸奥曲肽注射液治疗急性胰腺炎临床疗效观察[J].饮食保健,2019,6(33):70-71.
|
[8] |
高飞,尹纪来,王永存.乌司他丁联合奥曲肽对急性重症胰腺炎患者的临床研究[J].中国临床药理学杂志,2019,35(18):2013-2015.
|
[9] |
周克聚,刘静,高小虎,等.大柴胡汤加减联合生长抑素治疗重症急性胰腺炎临床观察[J].河南中医,2018,38(8):1152-1154.
|
[10] |
苏晓琳,陈苏宁.大承气汤合大柴胡汤加减辅助治疗急性中重症胰腺炎的临床观察[J].实用药物与临床,2017,20(5):560-562.
|
[11] |
杜奕奇.2019年版《中国急性胰腺炎诊治指南》解读[J].医学研究生学报,2020,33(3):234-237.
|
[12] |
李晓阳,娄华.大柴胡汤加减保留灌肠联合综合护理干预在重症急性胰腺炎患者中的应用效果观察[J].药品评价,2018,15(5):32-35.
|
[13] |
李小梅,鹿伟.大柴胡汤加减联合生长抑素对急性胰腺炎的临床疗效观察[J].世界中医药,2017,12(3):547-549.
|
[14] |
曾林.中西医结合治疗胰腺炎的现状和展望[J].临床医药文献电子杂志,2018,5(80):194.
|
[15] |
崔乃强,崔云峰,张淑坤.中西医结合治疗胰腺炎的现状与展望[J].临床肝胆病杂志,2017,33(5):843-848.
|
[16] |
王振东.大柴胡汤加减联合西药治疗重症急性胰腺炎临床疗效观察[J].亚太传统医药,2017,13(23):158-159.
|
|
|
|